Markntel Advisors’ report, Cell & Gene Therapy Drug Delivery Devices Research Report: Industry Trend, Business Growth, Size, Future Scope, Segmentation, Dynamics, and Forecast to 2028, offers a comprehensive guide for the growing industry. The expert team of analysts dedicated significant effort to gathering and evaluating the latest market data, resulting in a detailed and up-to-date report that offers valuable insights for individuals who rely on data-driven decisions, including business owners and analysts. The research report on the Cell & Gene Therapy Drug Delivery Devices presents well-researched facts and figures pertinent to the industry, whether the goal is to explore new markets, launch a new product, or maintain a competitive advantage.

Cell & Gene Therapy Drug Delivery Devices Market Industry Research Report & Market Summary:

The Global Cell & Gene Therapy Drug Delivery Devices Market is anticipated to grow at a CAGR of around 14% during the forecast period, i.e., 2023-28, says MarkNtel Advisors. The market is driven primarily by massive funding by numerous leading players in the technological advancements to bring cost-effective therapies & devices, coupled with the increasing number of FDA approvals for cell & gene therapies & clinical trials.

✅In case you missed it, we are currently revising our reports. Click on the below to get the latest research data with forecast for years 2025 to 2030, including market size, industry trends, and competitive analysis. It wouldn’t take long for the team to deliver the most recent version of the report.

If you’re interested in the assumptions considered in this study, you can download the PDF brochure-  https://www.marknteladvisors.com/query/request-sample/cell-gene-therapy-drug-delivery-devices-market.html

Cell & Gene Therapy Drug Delivery Devices Market Dynamics:

Key Driver-

The factors that are projected to drive the market in the coming years include the following:

• Substantial investments in R&D, particularly across the US, for the development of new & improved cell & gene therapies
• Mounting prevalence of genetic disorders & chronic diseases
• An increasing number of FDA approvals for cell & gene therapies & their clinical trials.

Cell & Gene Therapy Drug Delivery Devices Market Segmentation Analysis:

According to MarkNtel study the market is segmented into the following categories:

By Product Type

• Sub-retinal Injection Cannula
• Extension Tube
• Intravenous Catheter
• Sterile Insulin Syringe
  • Size 1.0 ML, 31-Gauge Needle
  • Size 0.5 ML, 22-Gauge Needle
• Pre-Filled Syringe
  • Size 1.0 ML, 22-26 Gauge Needle
  • Size 4.0 ML, 22-26 Gauge Needle
• Infusion Bags
  • Infusion Bags (Size 10 ML to 50 ML)
  • Infusion Bags (Size 68 ML)
  • Infusion Bags (Size 60 ML)
  • Infusion Bags (Size Up to 65 ML)

By Technology

• Microchip Technology
• Nano-Technology
• Lipid Nanoparticles

By Commercialized Drugs

• Luxturna
• Kymriah
• Yescarta
• Zolgensma
• Provenge
• Strimvelis

Of them all, Luxturna & Yescarta overpowered the Global Cell & Gene Therapy Drug Delivery Devices Market in 2021.

By End-User

• Pharmaceuticals & Biotechnology Company
• Academic & Research Institute
• Hospitals & Clinics

By Region

• North America
• South America
• Europe
• Middle East & Africa
• Asia-Pacific.

Of all the regions, North America attained more than 50% of the revenue share and is anticipated to prevail the same trend in the forecast period.

As indicated in the latest market research report published by Markntel Advisors, “Cell & Gene Therapy Drug Delivery Devices Research Report: Forecast (2023-2028)”, this report offers a detailed analysis of the industry, featuring insights into the Cell & Gene Therapy Drug Delivery Devices. It encompasses competitor and geographical analyses, as well as recent advancements in the market.

Browse Full Report Along with TOC and Figures - https://www.marknteladvisors.com/research-library/cell-gene-therapy-drug-delivery-devices-market.html

Top Companies Operating in the Cell & Gene Therapy Drug Delivery Devices Market:

• Amgen Inc.
• Bausch & Lomb Incorporated
• Becton, Dickinson and Company
• Bluebird bio Inc.
• Castle Creek Biosciences, Inc. (Fibrocell Science, Inc.)
• Dendreon Pharmaceuticals LLC
• Helixmith Co. Ltd (ViroMed Co., Ltd)
• Human Stem Cells Institute
• Kite Pharma Inc.
• Kolon TissueGene, Inc.
• Novartis AG
• Orchard Therapeutics plc.
• Pfizer Inc.
• Renova Therapeutics
• Spark Therapeutics Inc.
• uniQure N.V.
• Vericel Corporation.

Note - If there are any particular details you need that are not currently included in the report, we will be happy to provide them as part of our customization services.

*Reports Delivery Format - Market research studies from MarkNtel Advisors are offered in PDF, Excel, and PowerPoint formats. Within 24 hours of the payment being successfully received, the report will be sent to your email address*

Other Report:

• https://tach-amit.blogspot.com/2025/01/urban-air-mobility-market-landscape.html

Key Report Highlights:

• Market Dimensions & Projections
• Pricing Evaluation,
• Recent Strategic Moves by Companies,
• Primary Stakeholders,
• Analysis of Import and Export Trends,
• Competitive Landscape Assessment,
• Emerging Opportunities,
• Market Trends and Indicators

Frequently Asked Questions (FAQs)-

1. What are the industry’s overall statistics or estimates (Overview, Size- By Value, Forecast Numbers, Segmentation, Shares)?
2. What are the trends influencing the current scenario of the market?
3. What leading factors would propel and impede the industry across the geography?
4. How has the industry been evolving in terms of geography & Cell & Gene Therapy Drug Delivery Devices Market adoption?
5. How has the competition been shaping up across the geography?

6. Who are the key competitors, and what strategic partnerships or ventures are they coming up with to stay afloat during the projected time frame?

About Us –

We are a leading market research company, consulting, & data analytics firm that provides an extensive range of strategic reports on diverse industry verticals. We deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, & individuals, among others.

Our specialization in niche industries & emerging geographies allows our clients to formulate their strategies in a much more informed way and entail parameters like Go-to-Market (GTM), product development, feasibility analysis, project scoping, market segmentation, competitive benchmarking, market sizing & forecasting, & trend analysis, among others, for 15 diverse industrial verticals.

Contact Us –

Call + +1 628 895 8081, +91 120 4278433

Email: sales@marknteladvisors.com

Sales Office: 564 Prospect St, B9, New Haven, Connecticut, USA-06511

Address Corporate Office: Office No.109, H-159, Sector 63, Noida, Uttar Pradesh-201301, India